Results 111 to 120 of about 18,368 (174)

Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells. [PDF]

J Cancer Res Clin Oncol, 2023
Hong KU, Tagnedji AH, Doll MA, Walls KM, Hein DW.   +4 more
europepmc   +1 more source

Replication cycle timing determines phage sensitivity to a cytidine deaminase toxin/antitoxin bacterial defense system. [PDF]

PLoS Pathog, 2023
Hsueh BY, Ferrell MJ, Sanath-Kumar R, Bedore AM, Waters CM.   +4 more
europepmc   +1 more source

Author Correction: Cytidine deaminase activity increases in the blood of breast cancer patients. [PDF]

Sci Rep, 2022
Buhagiar-Labarchède G, Onclercq-Delic R, Vacher S, Berger F, Bièche I, Stoppa-Lyonnet D, Amor-Guéret M.   +6 more
europepmc   +1 more source

Cytidine deaminase activity increases in the blood of breast cancer patients. [PDF]

Sci Rep, 2022
Buhagiar-Labarchède G, Onclercq-Delic R, Vacher S, Berger F, Bièche I, Stoppa-Lyonnet D, Amor-Guéret M.   +6 more
europepmc   +1 more source

Combined inhibition of histone deacetylase and cytidine deaminase improves epigenetic potency of decitabine in colorectal adenocarcinomas. [PDF]

Clin Epigenetics, 2023
Tang Z, Liu L, Borlak J.
europepmc   +1 more source

A hybrid RNA-based reporter assay for robust quantification of cytidine deaminase activity. [PDF]

Nucleic Acids Res
Ligasová A, Horejšová M, Friedecký D, Pokorná E, Klener P, Koberna K.   +5 more
europepmc   +1 more source

Ago2 and a miRNA reduce Topoisomerase 1 for enhancing DNA cleavage in antibody diversification by activation-induced cytidine deaminase. [PDF]

Proc Natl Acad Sci U S A, 2023
Kobayashi M, Wakaguri H, Shimizu M, Higasa K, Matsuda F, Honjo T.   +5 more
europepmc   +1 more source

Adverse Prognostic Significance of Activation-Induced Cytidine Deaminase in Diffuse Large B-Cell Lymphoma Patients Treated With R-CHOP. [PDF]

Cancer Rep (Hoboken)
Hardianti MS, Anggorowati N, Setiawan SA, Bagaskoro MR, Kurnianda J, Taroeno-Hariadi KW, Purwanto I, Hutajulu SH.   +7 more
europepmc   +1 more source

Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levels. [PDF]

Cell Mol Life Sci, 2022
Mameri H, Buhagiar-Labarchède G, Fontaine G, Corcelle C, Barette C, Onclercq-Delic R, Beauvineau C, Mahuteau-Betzer F, Amor-Guéret M.   +8 more
europepmc   +1 more source

Development of a Real-Time Fluorescence-Based Deamination Assay and Identification of Inhibitors of Human Cytidine Deaminase. [PDF]

ACS Chem Biol
Moorthy R, Grillo MJ, Baur JW, Schmidt SA, Passow KT, Demir Ö, Tang J, Olson ME, Amaro RE, Harki DA.   +9 more
europepmc   +1 more source